pain arising from the viscera is the cardinal symptom of patients with irritable bowel syn- drome IBS a prevalent disease afflicting 10 - 20  of the world population -.

IBS patients generally experi- ence enhanced sensation to normal bowel functions re- duced perception threshold and tenderness in somatic re- ferral which are manifestations of peripheral and central hyperalgesia of the nervous system .

Sum- marized below are four categories of drugs generally pre- scribed to IBS patients in the clinics.Non-steroidal anti-inflammatory drugs NSAIDs ac- etaminophen and aspirin are used to treat bowel pain be- cause of the analgesic and anti-inflammatory effects.

The efficacy of linaclotide is supported by the outcomes of two phase III clinical trials on IBS-C patients from which alleviated abdominal pain and increased complete spontaneous bowel movement were reported  .

A recent clini- cal study on 18 general IBS patients reported beneficial ef- fects of cromoglycate which include reduced release of tryptase from intestinal biopsies attenuated expression of TLR2 and TLR4 and clinical improvement of bowel func- tion in the IBS-D subgroup  .

Reversal of visceral and cu- taneous hyperalgesia by local rectal anesthesia in irritable bowel syn- drome IBS patients.

Intestinal permeability in irritable bowel syn- drome patients effects of NSAIDs.

Clinical trial dextofisopam in the treatment of patients with diarrhoea-predominant or alternating irritable bowel syn- drome.

PubMed .Vahedi H Merat S Rashidioon A Ghoddoosi A Malekzadeh R. The effect of fluoxetine in patients with pain and constipation- predominant irritable bowel syndrome a double-blind randomized- controlled study.

The selective serotonin re- uptake inhibitor fluoxetine does not change rectal sensitivity and symptoms in patients with irritable bowel syndrome a double blind randomized placebo-controlled study.

